# Aegera Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aegera-therapeutics

- Industry: Biotechnology
- Headquarters: Montreal, Canada
- Website: www.aegera.com
- Total disclosed funding: $34M
- Latest round: Series C (Nov 20, 2006)
- Investors on record: 8

## About

Aegera Therapeutics Inc., is based in Quebec, Canada and is a clinical-stage biotechnology company, develops targeted therapeutics for various unmet medical needs.

## Funding rounds

- Series C, Nov 20, 2006, $14M — VenGrowth Capital Partners
- Series B, Feb 24, 2004, $20M — VenGrowth Capital Partners, GrowthWorks Capital, Fonds de Solidarité des Travailleurs du Québec, GeneChem, Fondaction, Innovatech Quebec, Desjardins Capital, Business Development Bank of Canada

## Investors

- VenGrowth Capital Partners (https://capitalatlas.ai/funds/vengrowth-capital-partners) — Series B, Series C
- GrowthWorks Capital (https://capitalatlas.ai/funds/growthworks-capital) — Series B
- Fonds de Solidarité des Travailleurs du Québec — Series B
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series B
- Fondaction (https://capitalatlas.ai/funds/fondaction) — Series B
- Innovatech Quebec (https://capitalatlas.ai/funds/innovatech-quebec) — Series B
- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Series B
- Business Development Bank of Canada — Series B